SCHEMBL2154050

SCHEMBL2154050

Cc1cc(OC(F)F)cnc1C(=O)Nc1ccc(F)c(C2(C(F)F)CNCC(N)=N2)c1

nearest known ligand 0.75

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.75
CTSD P07339 7/20 0.62
APP P05067 1/20 0.59
CYP2D6 P10635 1/20 0.59
BACE2 Q9Y5Z0 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2154463 1.00 BACE1 (0.75) BACE1CTSDAPPCYP2D6BACE2
SCHEMBL2153641 0.88 BACE1 (0.74) BACE1
SCHEMBL15361886 0.88 BACE1 (0.58) BACE1CTSDAPPCYP2D6BACE2
SCHEMBL360403 0.86 BACE1 (1.00) BACE1
SCHEMBL360794 0.86 BACE1 (1.00) BACE1
SCHEMBL2153909 0.84 BACE1 (0.72) BACE1CTSDAPPCYP2D6BACE2
SCHEMBL2153896 0.82 BACE1 (0.75) BACE1CTSD
SCHEMBL2153418 0.82 BACE1 (0.75) BACE1CTSD
SCHEMBL2153332 0.81 BACE1 (0.55) BACE1
SCHEMBL2153105 0.81 BACE1 (0.55) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011080176-A1 PYRAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS NOVARTIS AG (CH) 2011-07-07 WO claimed
WO-2011080176-A1 PYRAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS NOVARTIS AG (CH) 2011-07-07 WO disclosed